Epigenomics AG: Ad hoc Announcement According to #15 WpHG (German Securities Trading Act)
November 18, 2008 09:44 ET
|
Epigenomics AG
BERLIN, Germany and SEATTLE, Nov. 18, 2008 (GLOBE NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) (ISIN:DE000A0BVT96) and Abbott Molecular Inc. (Abbott) today have expand their non-exclusive strategic...
Epigenomics AG Reports Q3 and Nine Month 2008 Results
November 04, 2008 02:52 ET
|
Epigenomics AG
Key Figures (in EUR thousand)
- Revenues: 1,831 in 9M 2008; (9M 2007: 1,809)
- EBIT: -8,536 in 9M 2008; improved by 16% (9M 2007: -10,179)
- Net loss: -8,147 in 9M 2008; reduced by 17% (9M...
Epigenomics AG Reports PRESEPT Clinical Study Progress
October 27, 2008 04:43 ET
|
Epigenomics AG
-- Successfully qualified 17 PRESEPT clinical sites; 12 sites
initiated
-- Enrollment nearly 500 hundred subjects in first three months
-- Expanded clinical site network to include first...
Epigenomics AG Reports Successful Completion and Positive Results From Prostate Cancer Clinical Study
October 16, 2008 03:19 ET
|
Epigenomics AG
- Clinical study with patient cohorts from multiple clinical centers
completed
- All study endpoints met
- PITX2 biomarker classifies patients into groups at high and low
risk for...
Epigenomics AG: Voting Rights: Correction Release of a Voting Rights Notification (paragraph 21 Para. 1 WpHG) Released On 11 September 2008 in Accordance With paragraph 26, Para. 1 WpHG (German Securities Trading Act) With the Aim of a Europe-wide Distribution
September 19, 2008 06:34 ET
|
Epigenomics AG
BERLIN, Sept. 19, 2008 (GLOBE NEWSWIRE) -- Corrected Voting Rights Notification:
In correction of the voting rights notification dated 10 September 2008 and released by Epigenomics AG on 11...
Epigenomics AG: Voting Rights: Publication Pursuant to #26 Sect.1 WpHG (The German Securities Trading Act) With the Aim of Pan-European Distribution
September 11, 2008 09:26 ET
|
Epigenomics AG
BERLIN, Sept. 11, 2008 (GLOBE NEWSWIRE) -- Voting Rights Notification:
On 10 September 2008 Federated Investors Inc., Pittsburgh, PA, USA made the following notifications regarding the holding of...
Epigenomics Reports Positive Interim Results in Prostate Cancer Clinical Study
September 08, 2008 03:19 ET
|
Epigenomics AG
-- Clinical study of over 500 patient samples well on track for
completion in Q4 2008
-- Interim analysis representing approximately half of the cases
demonstrates statistical...
Voting Rights: Epigenomics AG: Publication Pursuant to Article 26 Para. 1 WpHG With the Aim of Pan-European Distribution
August 22, 2008 05:52 ET
|
Epigenomics AG
BERLIN, Aug. 22, 2008 (GLOBE NEWSWIRE) --
Issuer:
Epigenomics AG
- ISIN DE000A0BVT96 -
Kleine Prasidentenstr. 1
10178 Berlin
Deutschland
Voting Rights Notification:
On 21 August 2008...
Epigenomics AG Reports First Half of 2008 Results
August 05, 2008 03:14 ET
|
Epigenomics AG
Key Figures (in EUR thousand)
* Revenues: 1,511 in H1 2008; increased by 13% (H1
2007: 1,343)
* EBIT: -5,888 in H1 2008; improved by 15%
...
Epigenomics AG Receives Allowance for Key Patent in Europe
July 29, 2008 02:44 ET
|
Epigenomics AG
BERLIN and SEATTLE, July 29, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt Prime Standard:ECX), a molecular diagnostics company focusing on the development and commercialization of products for...